French Biotech Raises Over €22M to Launch a Gene Therapy to Restore Sight – Labiotech.eu (blog)
Labiotech.eu (blog) |
French Biotech Raises Over €22M to Launch a Gene Therapy to Restore Sight
Labiotech.eu (blog) Gensight Biologics has announced a capital increase that totals €22.5M and will support the launch of its gene therapy for blindness in Europe and the US. Gensight has decided to give an additional financial push to its lead candidate, GS010, a gene … |
